Market Trends Gilead reportedly settles CDC patent dispute over HIV drugsBy admin8996erT0allJanuary 15, 2025 Chris RyanGilead Sciences (NASDAQ:GILD) has reportedly settled a patent lawsuit with the federal government over its HIV drugs Truvada and…
